2017 Conference

2017: Is A/T Neurofeedback Training (NFT) a Successful Treatment Method for Women with Moderate to Severe Trait Anxiety: A Clinical Trial and Methodological Considerations (Plenary Session)

Since the late 1960s neurofeedback (NFT) has been used to treat adult individuals with anxiety disorders. Yet most related, evidence-based research studies were conducted between the mid-1970s and late 1990s. Therefore, NFT as an efficacious treatment for anxiety problems remains unclear. The literature research discloses that of few studies, most used sample sizes 10 subjects […]

2017: Is A/T Neurofeedback Training (NFT) a Successful Treatment Method for Women with Moderate to Severe Trait Anxiety: A Clinical Trial and Methodological Considerations (Plenary Session) Read More »

2017: Intelligence and EEG Measures of Information Flow: Efficiency and Homeostatic Neuroplasticity (Invited Speaker)

The purpose of this study was to explore the relationship between the magnitude of EEG information flow and intelligence. The electroencephalogram (EEG) was recorded from 19 scalp locations from 371 subjects ranging in age from 5 years to 17 years. The Wechsler Intelligence (WAIS-R) was administered to estimate I.Q. The phase slope index estimated the

2017: Intelligence and EEG Measures of Information Flow: Efficiency and Homeostatic Neuroplasticity (Invited Speaker) Read More »

2017: Impact of Developmental Trauma on Brain Function and Connectivity (Plenary Session)

The effect of trauma upon anyone can have a long lasting impact on their brain. For children, trauma can have a permanent impact on their developing brain, yet they may never meet the criteria for PTSD (Teicher, Anderson, Polcari, Anderson, & Navalta, 2002). For children however, traumatic stress can come from multiple and/or chronic and

2017: Impact of Developmental Trauma on Brain Function and Connectivity (Plenary Session) Read More »

2017: How Accurate Assessment Leads to Effective Intervention for ASD (Plenary Session)

Autism Spectrum Disorder (ASD) can be described as a “group of developmental disabilities that can cause significant social, communication and behavioral challenges“. The epidemiological data presented by the CDC reported that 1 in 68 children are currently diagnosed with ASD (CDC, 2016). The CDC has noted an increase in the prevalence of ASD since the

2017: How Accurate Assessment Leads to Effective Intervention for ASD (Plenary Session) Read More »

2017: Functional neuroimaging as a window into human brain function: applications to better understand and optimize neuromodulatory therapies (Keynote Speaker)

Functional brain imaging has opened a window into brain function in humans and has significantly enhanced our understanding of neural function and connectivity supporting aversive symptom states. Our research has shown that the brain is composed of multiple primary sensory and associative networks that activate and deactivate over time as distinct assemblies. These networks can

2017: Functional neuroimaging as a window into human brain function: applications to better understand and optimize neuromodulatory therapies (Keynote Speaker) Read More »

2017: Effects of Misdiagnosed ADHD May Decrease Children’s IQ, and the Efficacy of QEEG and Neurofeedback in the Assessment and Treatment of misdiagnosed ADHD children: A Clinical Case Series (Plenary Session)

Mild Traumatic Brain Injury (MTBI), commonly referred to as a concussion, can be described as a brain injury resulting from acute trauma to the head. (Carroll, Cassidy, Holm, Kraus, & Coronado, 2004) In the United States It is reported that up to 1.7 million people sustain a Traumatic Brain Injury annually which has resulted in

2017: Effects of Misdiagnosed ADHD May Decrease Children’s IQ, and the Efficacy of QEEG and Neurofeedback in the Assessment and Treatment of misdiagnosed ADHD children: A Clinical Case Series (Plenary Session) Read More »

2017: Depression Two Years Post Four Channel Multivariate Coherence Neurofeedback Treatment (Plenary Session)

Having high prevalence and a persistent nature, it becomes clear that depression can be blighting for those struggling with its symptoms (Kessler & Bromet, 2013). According to the World Health Organization, there are more than 300 million people worldwide who are suffering from depression (WHO, 2017). Many options for treatment, such as psychotherapy and medication,

2017: Depression Two Years Post Four Channel Multivariate Coherence Neurofeedback Treatment (Plenary Session) Read More »

2017: Buddhism and Neurofeedback: A Conversation with the Dalai Lama (Plenary Session)

In 2014 a group of Neurofeedback instructors trained five doctors of Tibetan medicine at the Men Tsee Kang Clinic in Dharamsala, India in how to use Neurofeedback. They left 4 Cygnet systems with them with intent that they would be primarily used for treating the PTSD of Tibetan refugees escaping torture and brutal treatment by

2017: Buddhism and Neurofeedback: A Conversation with the Dalai Lama (Plenary Session) Read More »

2017: An Analysis of Long-Term and Secondary Outcomes of a Randomized Controlled Trial of Neurofeedback to Treat Chemotherapy-Induced Peripheral Neuropathy (Plenary Session)

Background: CIPN is a common side effect of chemotherapy, leading to impairment in daily activities and diminished quality of life. Neurofeedback (NF) is a brain-training paradigm that induces neuroplasticity to modulate brain activity and we have previously shown it leads to improved CIPN symptoms that were mediated by NF-induced brain changes. Methods: Seventy-one (62 female;

2017: An Analysis of Long-Term and Secondary Outcomes of a Randomized Controlled Trial of Neurofeedback to Treat Chemotherapy-Induced Peripheral Neuropathy (Plenary Session) Read More »

Current Status
Not Enrolled
Price
20
Get Started

We’ve Moved…

To accommodate the organization’s growing needs, we have decided to move our office to a new location.

2146 Roswell Road

Suite 108, PMB 736

Marietta, GA 30062

USA

Scroll to Top

Are you having problems clicking next on the membership form?

You must have 3rd party cookies set to “Always Accept.”

Internet Explorer 7 on Windows

  • Click the “Tools” menu
  • Click “Internet Options”
  • Select the “Privacy” tab
  • Option 1: To enable third-party cookies for all sites
  • Click “Advanced”
  • Select “Override automatic cookie handling”
  • Select the “Accept” button under “Third-party Cookies” and click “OK”

Firefox 3 on Windows

  • Click the “Tools” menu
  • Click “Options…”
  • Select the “Privacy” menu
  • Make sure “Keep until” is set to “they expire”
  • Option 1: To enable third party cookies for ALL sites: Make sure “Accept third-party cookies” is checked

Safari on Apple OS X:

  • Click the “Safari” menu
  • Click “Preferences…”
  • Click the “Security” menu
  • For “Cookies and website data” unselect “Block all cookies”
  • For “Website tracking”, unselect “Prevent cross-site tracking”
Safari enable cookies for membership purchase.

Firefox 3 on Apple OS X:

  • Click the “Firefox” menu
  • Click Preferences…
  • Click the Privacy menu
  • Make sure “Keep until” is set to “they expire”
  • Option 1: To enable third-party cookies for ALL sites: Make sure “Accept third-party cookies” is checked

Google Chrome on Windows

  • Select the Wrench (spanner) icon at the top right
  • Select “Options”
  • Select the “Under the Hood” tab
  • Select “Allow all cookies” under “Cookie Settings” and click “Close”

Internet Explorer 6 on Windows

  • Click the “Tools” menu
  • Click “Internet Options”
  • Select the “Privacy” tab
  • Move the settings slider to “Low” or “Accept all cookies”
  • Click “OK”

Opera 9 on Windows

  • Click the “Tools” menu
  • Click “Preferences…”
  • Click the “Advanced” tab
  • Select “Cookies” on the left list
  • Make sure “Accept cookies” is selected and uncheck “Delete new cookies when exiting Opera”
  • Click “OK”